ROP gains from strength across its businesses, acquired assets and shareholder-friendly policies. High operating expenses and debt level remain concerns.

CentralReach, a Holmdel company whose software is used to treat people diagnosed with autism, has been sold for $1.85 billion ...

A tech leader in autism and intellectual and development disabilities care, CentralReach's move will help position the company for even greater growth.

ROP's acquisition of CentralReach will enable it to strengthen its product offerings and boost its Application Software segment.

In a report released today, Terry Tillman from Truist Financial reiterated a Buy rating on Roper Technologies (ROP – Research Report). The ...

As part of the acquisition, CentralReach will remain independent, preserving its team, brands, products and mission.

Roper Technologies Inc. announced Monday its plans to acquire CentralReach, a leading software provider specializing in ...

Roper Technologies, which posted $7.04 billion in revenue in 2024, expects Fort Lauderdale-based CentralReach to contribute ...

Roper Technologies to acquire CentralReach for $1.65 billion, expects 20%+ organic revenue growth and plans to integrate into ...

Roper Technologies agreed to acquire healthcare technology company CentralReach from Insight Partners for about $1.65 billion ...

Roper (NYSE: ROP) acquired Denver software and payments platform Procare Solutions for $1.75 billion in January 2024 and ...

Insight Partners has agreed to sell CentralReach, a Fort Lauderdale, Florida-based provider of autism and IDD care software for applied behavior analysis, multidisciplinary therapy, and special ...